Home About Us Contact Us

Official Journals By StatPerson Publication

Table of Content Volume 9 Issue 3 - March 2019

 

Seroprevalence and seasonal trend of dengue virus infection at tertiary care hospital, Valsad

 

Mehul Patel1, Vicky Gandhi2*, Hiral Patel3, Alka Nerurkar4

 

1,3Tutor, 2Assistant Professor, 4Professor and HOD, Department of Microbiology, G.M.E.R.S. Medical College, Valsad, Gujarat, INDIA.

Email: vickygandhi15@gmail.com

 

Abstract               Background: Dengue is a vector borne febrile illness affecting tropical and subtropical regions of world including India. It is major public health problem in India because of rapid explosive urbanisation and absence of specific antiviral treatment. It presents with mild fever and ends with life threatening complication like Dengue Shock Syndrome or Dengue Hemorrhagic Fever. Regular epidemiological surveillance and appropriate vector control measures is the only way to prevent transmission of diseases. Aims and Objective: To study the prevalence of Dengue virus infection with seasonal trend at tertiary care hospital, Valsad. Materials and Methods: The study was conducted from July 2015 to December 2018 at tertiary care hospital, Valsad. Blood samples from suspected cases were collected and tested for NS1 antigen detection by Dengue NS1 Ag enzyme immunoassay kit and for IgM antibody by NIV Dengue IgM capture ELISA kit based on their duration of illness. Result: Out of total 2830 serum samples tested, 674 (23.81%) were found positive for dengue virus infection. 461 samples were positive from male patients and 213 samples were positive from female patients with male female ration of 2.1:1.The most commonly affected age group was below 20 years of age (25.84%) followed by 21-40 years of age group (24.54%). There is a gradual raise in the positivity rates from July reaching a pick by October.  Conclusion:  The study concludes that Dengue infection has been established in semi urban area of Valsad with male predominance. Dengue virus infection is high during monsoon and post monsoon seasons due to increase vector breeding. Continuous epidemiological surveillance, appropriate vector control measures and early diagnosis by ELISA are necessary for effective Dengue control programme.

Key Word: Dengue Shock Syndrome, Dengue Hemorrhagic Fever, Dengue NS1 Ag enzyme immunoassay kit, NIV Dengue IgM capture ELISA kit

 

 

 

INTRODUCTION

Dengue fever is an acute febrile illness caused by Arbovirus affecting mainly the tropical and subtropical regions of the world.1 It is endemic in over 100 countries with 2.5 million people at risk.2 The southeast asian region mainly countries like India, Sri Lanka, Bangladesh are experiencing increase in reported cases of Dengue with nearly 75% of current global disease burden.3 The name ‘Dengue’ is derived from the Swahili word ‘Ki denga pepo’, which means ‘sudden seizure by the demon’. Following the Philadelphia epidemic in 1780, it was called as ‘break bone fever’ by Benjamin Rush.4 Dengue virus is an arthropod borne virus Arbovirus, belonging to family Flaviviridae and genus Flavivirus. It consists of three structural (C, prM and E) and seven non structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B AND NS5) proteins. The dengue virus is transmitted by Aedes aegypti and Aedes albopictus mosquito.5, 6 Dengue virus causes illness ranging from self limiting classical dengue fever (CDF) to life threatening complications like Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS).7The mortality rate of DHF in most countries is 5%, likely seen in young children and adult.8, 9 Dengue is endemic in Indian subcontinent and associated with urban epidemic and major health problem. The first epidemic of Dengue infection was seen in Kolkata in 1963 and after that several epidemics have been seen in different state of India.10, 11, 12, 13 It is caused by four distinct serotype of virus; DEN1, DEN2, DEN3 and DEN4.6, 14Recovery from infection by one serotype can confer lifelong immunity to that serotype. Primary infection with any serotype cause classical dengue fever, but secondary infection with other serotypes cause more complication like DHF and DSS. It is due to antibody mediated immune enhancement.5, 7, 15

 

MATERIALS AND METHOD

The study was conducted at Microbiology Department, GMERS Medical College, Valsad from July 2015 to December 2018. Blood samples from all clinically suspected cases of Dengue fever with or without hemorrhagic manifestation were collected from all patients under total aseptic precautions. The clinical basis for suspecting dengue infected patient was based on WHO definition.16 Serum samples were tested for NS1 antigen detection by using commercially available Platelia Dengue NS1 Ag enzyme immunoassay kit manufactured by Bio Rad, France. Samples were tested for IgM antibody detection by using NIV Dengue IgM capture ELISA kit manufactured by National Institute of Virology, Pune. The choice of diagnostic test was based on duration of onset of illness. For confirmation of dengue infection, Government of India recommends use of ELISA based antigen detection test (NS1) for diagnosing the cases from the first day onwards and antibody detection test IgM capture ELISA (MAC-ELISA) for diagnosing after the fifth day of onset of dieases.17, 18

RESULT

Total 2830 serum samples of suspected cases were tested during the study period, out of which 674 (23.81%) samples were positive for Dengue infection. From total 2830 samples, 1699 samples were tested for Dengue NS1 antigen and 1131 samples were tested for Dengue IgM antibody. Out of 1699 samples which were tested for Dengue NS1 antigen, 366 were positive and 1131 samples, which were tested for Dengue IgM antibody, 308 were positive. (Table 1) Out of total 2830 samples, 1553 patients were male of which 461 (29.68%) were positive and 1277 patients were female of which 213 (16.67%) were positive for dengue infection (Figure 1).  Age wise prevalence of dengue virus infection indicates that seroprevalence of dengue virus infection is high in children and young adult age group 0-20 years (215/832- 25.85%) than in adult group 21-40 years (361/1471-24.54%) (Figure 2). Age wise distribution of NS1 antigen detection and IgM antibody detection showed individually in table 2. Analysis of monthly data suggested that samples and seropositivity were maximum during months of July-December with highest sample in October month of every year. (Figure 3)


 

Table 1: Seroprevalence of Dengue virus infection

Test

Total

Positive

Percentage

NS1 antigen

1699

366

21.54%

IgM antibody

1131

308

27.23%

Total

2830

674

23.81%

 

Table 2: Age wise prevalence of dengue virus infection

Age Group

NS1 Antigen

IgM antibody

 

Total

Positive

Total

Positive

0-20 Years

465

111

367

104

21-40 Years

919

210

552

151

41-60 Years

252

36

168

45

>60 Years

63

9

44

8

Total

1699

366

1131

308

 

                                    Figure 1                                                                        Figure 2                                                               Figure 3

Figure 1: Sex wise prevalence of dengue infection; Figure 2: Age wise distribution of Dengue virus infection. Figure 3: Seasonal trend of dengue virus infection

 


DISCUSSION

Outbreaks of Dengue virus infection are reported in India every year. It starts with mild fever to life threatening complication like Dengue Shock Syndrome and Dengue Hemorrhagic Fever. It is necessary to implicate control and preventive measures and early diagnosis of dengue virus infection. In our study, Seroprevalence rate of Dengue virus infection was 23.81%. These finding are in accordance with other studies conducted in India. 10, 12, 19, 20 Our hospital is tertiary care hospital so samples come from surrounding rural area of Valsad. Rapid, unplanned and unchecked construction development in rural area is another contributing factor to fertile breeding of mosquitoes. The higher prevalence of Dengue virus infection was noted amongst males than females. The male to female ratio in our study was 2.1:1 which correlates with other studies.10, 19, 21  The lower infection in female was due to they remain stayed at home so less exposed to day biting mosquitoes while males doing more outdoor activities had higher infection rate.  The most common age group of infection was below 20 years of age which includes children and young adults. These finding are consistent with several studies done in India 10, 13, 20 and with international studies.22 The children were more affected due to true endemicity of diseases in this area. For seasonal trend, when we analysed month wise data it noted that suspected cases and positivity rate start increasing from July, reached picked in September and October and declines after December. It is mainly due to monsoon and post monsoon activities. High Seroprevalence during this month was due to stagnation of water during rainfall which acts as fertile new breeding place for mosquitoes. Proper vector control measures if taken during initial rainy seasons, it helps in reduce diseases transmission and prevent epidemic of dengue virus infection.10, 20

 

CONCLUSION

Our study concludes that Dengue virus infection was seen more in male of children and young adult age group with predominance in monsoon and post monsoon seasons. Because of absence of any specific treatment against dengue and more life threatening complication, early diagnosis by NS1 antigen detection and effective vector control is the only method to prevent and control dengue transmission. A seasonal trend observed in dengue infection during monsoon and post monsoon seasons indicate to start early vector control measures and control new breeding mosquito’s sites occurred due to stagnant water. The proper mosquito vector control also helps in reduce other mosquitoes borne infection like malaria, chikungunya and filarial during monsoon seasons. 

 

REFERENCES

    • Gupta N, Srivastava S, Jain A et al. Dengue in India. Indian Journal of Medical Research 2012; 136:373-390
    • Apurba Sankar Sastry, Sandhya Bhat.  Essentials of Medical Microbiology 2016; 1st edition: 489-492
    • Sultana N, Biswas SK et al. Seroprevalence of Dengue fever in Chittagong, Bangladesh. Chittagong Maa O Shishu Hospital Medical College Journal 2013;12(1):38-40
    • Ananthnarayan R, Paniker CKJ, Arbovirus. Ananthanarayan and Paniker’s Textbook of Microbiology. 9th edition;2016:524-526
    • Monath TP. Dengue: The risk to developed and developing countries. Proceeding of National Academy of Science, USA 1994;91:2395-2400
    • Gubler DJ. Dengue and dengue hemorrhagic fever. Clinical Microbiology Review 1998;11:480-496
    • Martina BE, Koraka P et al. A Dengue virus pathogenesis: an integrated view. Clinical Microbiology Review 2009;22:564-581
    • WHO 2002. Dengue and Dengue hemorrhagic fever. Fact sheet no 117, Geneva.
    • World Health Organisation. Key issue in dengue vector control towards the opererationalisation of a global strategy: report of consultation. Geneva: WHO;1995
    •  Garg A, Garg J, Rao YK et al. Prevalence of dengue among clinically suspected febrile episodes at a teaching hospital in north India. Journal of Infectious Diseases and Immunity 2011;3:85-89
    •  Kalawat U, Sharma KK, Reddy SG. Prevalence of dengue and chikungunya fever and their coinfection. Indian Journal of Pathology and Microbiology.2011;54:844-846
    •  Paramasivan R, Thenmozhi V, Hiriyan J et al. Serological and entomological investigations of an outbreak of dengue fever in certain rural areas of Kanyakumari district, Tamil Nadu. Indian Journal of Medical Reasearch.2006;123:697-701
    •  Gunasekaran P, Kaveri K, Mohana S et al. Dengue disease status in Chennai (2006-2008): A retrospective analysis. Indian Journal of Medical Research 2011;133:322-325
    •  Lambrechts L, Scott TW, Gubler Dj et al. Consequeces of expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Neglected Tropical Diseases 2010;4:e646 
    •  Sekaran SD, Subramaniam G, Kanthesh BM. Sensitivity of dengue virus NS1 detection in primary and secondary infection. African Journal of Microbiology Reasearch 2009;3:105-110
    •  World Health organisation/Research and Training in Tropical Diseases. Handbook for clinical management of dengue, Geneva. Chapter1.3 Dengue diagnostic for clinicians;2012:15-21
    • National Guideline for Clinical Management of Dengue Fever under National Vector Born Diseases Control Programme by Government of India and WHO 2015. Chapter 4;4.3:17
    •  Midterm plan for prevention and control of dengue and chikunguniya, New Delhi. National Vector Borne Diseases Control Programme. Directorate of Health Services, Ministry of Health and Family Welfare. Government of India;2011
    •  Manisha Patankar, Bhaumik Patel et al. Seroprevalence of dengue in Gujarat, Western India: A study at a tertiary care hospital. International Journal of Medical Science and Public Health 2014;3(1):16-18
    •  Sharma Y, Kaur M, Singh S et al. Trend of dengue cases admitted to a government hospital, Delhi – 5 year study (2006-2010): A look into the age shift. International Journal of Preventive Medicine. 2012;3(8):537-543
    •  Gupta E, Dar L, Kapoor G. The changing epidemiology of dengue in Delhi, India. Virology Journal 2006;3:92
    •  Martin JLS, Brathwaite O, Zambrano B et al. The epidemiology of dengue in the Americas over the last three decades; A worrisome reality. American Journal of Tropical Medicine 2010;82:128-135.